Diagnostic Accuracy Of Screening & Treatment Of Post–Acute Coronary Syndrome Depression: A Systematic Review

On November 15, 2017, the Agency for Healthcare Research and Quality released this systemic review on the diagnostic accuracy of screening and treatment of post-acute coronary syndrome depression. The key messages of the review included:

 The Beck Depression Inventory (BDI)-II screen tool is the most studied and is as accurate in this population as in others.
 Available depression-screening tools may miss 3 percent of people with depression, but less than 50 percent of those who screen positive have clinically confirmed depression.
 Enhanced care interventions that integrate psychiatric treatment into cardiology and primary care settings improve depression symptoms . . .